title: Relationship of oxypurine release to contractile failure in dinitrophenol-treated rat skeletal muscle.
abstract: The efflux of hypoxanthine and uric acid from skeletal muscle has been noted to follow exercise and metabolic stress both in vivo and in vitro. Since the action of xanthine oxidase and hypoxanthine generates free radicals with potential damaging effect on the muscle membranes, an in vitro model was used to study the relationship of metabolic stress, oxypurine release and muscle contraction. When rat epitrochlearis muscle was exposed to the mitochondrial uncoupler dinitrophenol at 37 degrees C, lactate release was pronounced and hypoxanthine and uric acid appeared in the incubating medium. The twitch tension, in response to supramaximal stimulation, was reduced to less than 5% of the initial value. When the same experiment was repeated at 27 degrees C, hypoxanthine and uric acid formation was inhibited, although lactate release indicated that metabolic stress was still present. Twitch tension was relatively preserved (57% of the initial value). The lower temperature did not alter the decrease in ATP and phosphocreatine levels in the muscle which is produced by dinitrophenol. There was an inverse relationship between oxypurine release and twitch tension in individual muscles (r = 0.80, P < 0.01 for hypoxanthine and r = 0.95, P < 0.0002 for uric acid). Xanthine dehydrogenase/xanthine oxidase was detected in muscle and between 16 and 22% of the activity was in the oxidase form.
authors.affiliation: Department of Medicine, Heritage Medical Research Centre, University of Alberta, Edmonton, Canada.
authors.forename: R
authors.initials: R
authors.lastname: Majumdar
authors.forename: V A
authors.initials: VA
authors.lastname: Cwik
authors.forename: G
authors.initials: G
authors.lastname: Solonynko
authors.forename: M H
authors.initials: MH
authors.lastname: Brooke
mesh_terms: D019297:2,4-Dinitrophenol; D000255:Adenosine Triphosphate / Q000502:physiology; D000818:Animals; D004140:Dinitrophenols / Q000494:pharmacology*; D019271:Hypoxanthine; D007042:Hypoxanthines / Q000032:analysis / Q000378:metabolism; D066298:In Vitro Techniques; D008297:Male; D009119:Muscle Contraction / Q000187:drug effects / Q000502:physiology; D009132:Muscles / Q000187:drug effects / Q000378:metabolism / Q000502:physiology*; D010725:Phosphocreatine / Q000502:physiology; D011687:Purines / Q000378:metabolism*; D051381:Rats; D017207:Rats, Sprague-Dawley; D014475:Uncoupling Agents / Q000494:pharmacology*; D014527:Uric Acid / Q000032:analysis / Q000378:metabolism; D014968:Xanthine Dehydrogenase / Q000378:metabolism; D014969:Xanthine Oxidase / Q000378:metabolism
chemical_list: D004140:Dinitrophenols; D007042:Hypoxanthines; D011687:Purines; D014475:Uncoupling Agents; D010725:Phosphocreatine; D014527:Uric Acid; D019271:Hypoxanthine; D000255:Adenosine Triphosphate; D014968:Xanthine Dehydrogenase; D014969:Xanthine Oxidase; D019297:2,4-Dinitrophenol